Delayed administration of interleukin-1 receptor antagonist reduces ischemic brain damage and inflammation in comorbid rats

Many neuroprotective agents have been effective in experimental stroke, yet few have translated into clinical application. One reason for this may be failure to consider clinical comorbidities/risk factors in experimental models. We have shown that a naturally occurring interleukin-1 receptor antago...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Pradillo, Jesus M, Denes, Adam, Greenhalgh, Andrew D, Boutin, Herve, Drake, Caroline, McColl, Barry W, Barton, Eleanor, Proctor, Spencer D, Russell, James C, Rothwell, Nancy J, Allan, Stuart M
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Nature Publishing Group 2012
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3434631/
https://ncbi.nlm.nih.gov/pubmed/22781338
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jcbfm.2012.101
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg